Search & Analyze

Granules India Ltd.

841.10+4.50 (+0.54%)

BSE · 30 Oct, 4:01 PM

: ₹22,901.23 Cr
: 34.58
: 43,368
: ₹859.75 - ₹837.60
: ₹922.10 - ₹520.05

Granules India Ltd. (GRANULES) share price closed at ₹841.10 on the BSE on Friday, October 30, 2026, up by 0.54% from its of ₹836.60. In that session GRANULES reached a of 859.75 and of 837.60. The for the session was 848.56. The stands at 842.73 and is at 738.48. Looking at , the stock ended the session moving sideways.

Stock Overview

₹837.90

₹836.60

₹848.56

₹842.73

Price 0.19% below

₹738.48

Price 13.90% above

Key Fundamentals

: 22,901.23 Cr₹22.90 Thousand Crore
: 24.28
: 34.58
: 4.67
: 179.70
: 1,283.59 Cr₹1.28 Thousand Crore
: 0.21 %
Sector
Industry: Pharmaceuticals & Drugs
: 14.13
: 0.28

Industry Comparison

Ratio	Company	Sector
	34.58	44.77
	0.28	0.20
	4.67	4.61
	1.80	1.81
	0.21 %	0.11 %
Operating Margin	11.83 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
Granules India Ltd. GRANULES	841.10	34.58	22,901.23	0.21	179.96	59.77%	1,476.77	22.04%	15.74

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,179.87	966.62	1,137.70	1,197.43	1,210.11	1,296.99	1,387.94	1,470.61	1,476.77
Expenses	920.60	763.30	907.41	945.07	963.39	1,018.76	1,079.84	1,118.50	1,137.87
	259.27	203.32	230.29	252.36	246.71	278.23	308.10	352.10	338.91
	21.97%	21.03%	20.24%	21.07%	20.39%	21.45%	22.20%	23.94%	22.95%
	2.06	3.26	5.68	32.67	-9.57	-1.15	-3.64	24.69	2.27
Interest	27.02	25.67	26.57	23.98	23.78	29.19	28.69	32.69	21.12
	52.87	52.52	56.61	63.50	68.85	72.02	73.53	81.75	79.65
	181.44	128.38	152.79	197.55	144.53	175.87	202.23	262.36	240.40
	25.79%	24.26%	23.03%	23.04%	22.06%	25.74%	25.72%	23.17%	25.14%
	134.65	97.23	117.60	152.03	112.64	130.61	150.21	201.57	179.96
	5.56	4.01	4.85	6.27	4.64	5.38	6.19	8.13	7.26

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	3,764.92	4,511.92	6,550.27	7,450.74	10,021.61
	3,764.92	4,511.92	4,506.37	4,481.61	5,365.64
EXPENDITURE :
Increase/Decrease in Stock	-152.78	-45.37	-186.97	0.76	-224.08
Raw Material Consumed	2,036.42	2,352.65	2,208.22	1,724.94	2,099.78
Power & Fuel Cost	74.66	95.69	100.64	100.74	128.87
Employee Cost	366.44	420.35	550.24	619.66	849.14
Other Manufacturing Expenses	302.30	277.45	412.56	475.96	606.73
General and Administration Expenses	130.84	184.45	207.44	273.21	326.91
Selling and Distribution Expenses	247.45	280.00	290.63	297.79	333.41
Miscellaneous Expenses	37.96	33.39	67.62	43.32	59.75
	3,043.30	3,598.60	3,650.39	3,536.37	4,180.50
Operating Profit (Excl OI)	721.63	913.31	855.98	945.24	1,185.14
	18.22	14.29	4.40	12.92	20.33
	739.85	927.60	860.38	958.16	1,205.47
Interest	23.21	55.93	105.82	103.24	114.35
PBDT	716.63	871.67	754.56	854.92	1,091.12
	158.63	184.49	207.33	225.50	296.14
Profit Before Taxation & Exceptional Items	558.00	687.17	547.23	629.42	794.98
Exceptional Income / Expenses				30.75	-10.00
	558.00	687.17	547.23	660.17	784.98
Provision for Tax	145.24	170.58	141.92	158.65	189.96
	412.76	516.60	405.31	501.52	595.02
Extra items	0.00	0.00	0.00	0.00	0.00
Consolidated Net Profit	412.76	516.60	405.31	501.52	595.02
Profit Balance B/F	1,356.61	1,732.15	2,230.18	2,596.87	3,059.48
Appropriations	1,769.37	2,248.74	2,635.49	3,098.39	3,654.50
Equity Dividend %	150.00%	150.00%	150.00%	150.00%	175.00%
	16.64	21.34	16.72	20.68	24.01
Adjusted EPS	16.64	21.34	16.72	20.68	24.01

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	24.80	24.20	24.24	24.25	24.78
Share Warrants & Outstandings	16.72	18.02	18.30	13.71	365.63
Total Reserves	2,545.02	2,792.68	3,183.00	3,677.62	4,694.59
Reserve excluding Revaluation Reserve	2,545.02	2,792.68	3,183.00	3,677.62	4,694.59
Revaluation reserve			0.00
	2,586.54	2,834.91	3,225.54	3,715.58	5,085.00
Minority Interest	0.56
Secured Loans	233.70	148.64	68.97	311.51	297.15
Deferred Tax Assets / Liabilities	12.54	6.22	-14.01	-36.47	-26.81
Other Long Term Liabilities	8.28	70.60	83.20	159.19	160.95
Long Term Provisions	28.31	29.26	37.88	31.76	47.79
Total Non-Current Liabilities	282.83	254.73	176.04	465.99	479.08
Trade Payables	638.61	782.13	749.53	726.07	672.80
Other Current Liabilities	200.85	193.19	261.08	304.61	336.07
Short Term Borrowings	765.58	810.88	1,054.24	922.56	1,025.34
Short Term Provisions	36.56	27.31	17.45	49.92	57.81
Total Current Liabilities	1,641.60	1,813.50	2,082.29	2,003.16	2,092.03
Total Liabilities	4,511.53	4,903.14	5,483.88	6,184.73	7,656.10
Gross Block	2,461.77	2,981.22	3,351.81	3,882.08	4,987.94
Less: Accumulated Depreciation	920.59	1,070.30	1,256.20	1,455.61	1,737.82
	1,541.17	1,910.92	2,095.62	2,426.47	3,250.12
	311.92	228.04	259.54	436.95	406.49
Non Current Investments	19.67	21.21	21.52	22.04	0.84
Long Term Investment	19.67	21.21	21.52	22.04	0.84
Long Term Loans & Advances	89.47	157.48	190.00	179.51	226.32
Other Non Current Assets			0.00	1.04	1.64
Total Non-Current Assets	2,006.54	2,328.99	2,578.83	3,069.25	3,888.46
Inventories	978.55	1,149.41	1,300.55	1,342.82	1,673.03
Sundry Debtors	924.95	948.54	985.83	942.22	909.37
Cash and Bank	409.46	312.79	386.39	596.38	949.06
Other Current Assets	61.67	49.22	46.28	53.92	73.24
Short Term Loans and Advances	130.35	114.19	186.00	180.15	162.95
Total Current Assets	2,504.99	2,574.15	2,905.05	3,115.48	3,767.65
Net Current Assets (Including Current Investments)	863.39	760.65	822.76	1,112.32	1,675.62
Total Assets	4,511.53	4,903.14	5,483.88	6,184.73	7,656.10
	0.99	3.04	3.04	3.04	0.93
Total Debt	1,092.76	1,058.62	1,223.23	1,285.79	1,338.13
	103.62	116.38	132.33	152.63	190.45
Adjusted Book Value	103.62	116.38	132.33	152.63	190.45

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	558.00	687.17	547.23	660.17	784.98
Adjustment	176.29	237.69	328.80	344.14	390.12
Changes In working Capital	-257.19	-10.31	-246.32	6.02	-141.66
Cash Flow after changes in Working Capital	477.11	914.55	629.71	1,010.32	1,033.45
Cash Flow from Operating Activities	332.06	738.75	439.41	866.57	793.25
Cash Flow from Investing Activities	-380.12	-191.36	-360.16	-691.29	-773.21
Cash Flow from Financing Activitie	190.00	-440.29	7.66	-92.51	379.29
Net Cash Inflow / Outflow	141.94	107.10	86.92	82.77	399.33
Opening Cash & Cash Equivalents	41.84	184.71	291.56	381.10	466.11
Cash & Cash Equivalent on Amalgamation / Take over / Merger					2.41
Effect of Foreign Exchange Fluctuations	0.94	-0.25	2.63	2.24	12.39
Closing Cash & Cash Equivalent	184.71	291.56	381.10	466.11	880.24

Ratios

Valuation

34.58

4.67

18.14

4.09

24.28

179.70

Profitability

14.13

15.74

8.60

11.83

5.94

Leverage & Liquidity

0.28

1.80

7.86

Returns

0.21

1.45

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	38.87	38.87	38.85	38.84	38.82	38.82	38.82	38.02	38.02	37.39
	34.51	34.34	35.44	37.59	36.77	32.01	31.03	32.32	33.61	35.57
	26.62	26.80	25.72	23.55	24.41	29.17	30.15	29.67	28.38	27.05
	61.13	61.13	61.15	61.16	61.18	61.18	61.18	61.98	61.98	62.61
No. of Shareholders	1,79,870	2,02,198	1,77,554	1,69,802	1,69,700	1,65,542	1,63,184	1,60,286	1,69,422	1,82,022

Mutual Funds Invested(91)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 29 active funds hold 3.75% in Granules India Ltd., contributing to ₹865 Cr of holdings

Fund				As of
OB Old Bridge Focused Fund - Growth - Direct PlanEquity - Focused Fund	139.72	3.08	16,50,500	Sep '26
AB Aditya Birla Sun Life Multi-Cap Fund - Growth - Direct PlanMulti Cap Fund	135.83	1.87	16,04,464	Sep '26
AB Aditya Birla Sun Life Small Cap Fund - Growth - Direct PlanSmall cap Fund	119.68	1.96	14,13,691	Sep '26
AB Aditya Birla Sun Life Value Fund - Growth - Direct PlanEquity - Value Fund	118.78	1.78	14,03,100	Sep '26
SU Sundaram Aggressive Hybrid Fund - Growth - Direct PlanHybrid - Aggressive Hybrid Fund	105.12	1.20	12,41,794	Sep '26
TR TRUSTMF Small Cap Fund - Growth - Direct PlanSmall cap Fund	55.73	1.44	6,58,330	Sep '26
SU Sundaram Small Cap Fund - Growth - Direct PlanSmall cap Fund	42.33	1.03	5,00,000	Sep '26
SU Sundaram Multi Asset Allocation Fund - Growth - Direct PlanHybrid - Multi Asset Allocation	36.14	1.13	4,26,926	Sep '26
AS Altiva Hybrid Long-Short Fund - Growth - Direct PlanHybrid - Long-Short Fund	34.53	0.31	4,07,852	Sep '26
NI Nippon India Nifty Smallcap 250 Index Fund - Growth - Direct PlanIndex Funds - Other	19.31	0.56	2,28,057	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-23	Board Meeting	Quarterly Results
2026-07-09	Board Meeting	Quarterly Results
2026-05-04	AGM

Insider Trading

Date	Person	Category	Transaction Type	Shares
2026-10-23	Chigurupati Uma Devi	Preferential Offer	Buy	24,880,342
2026-10-23	Chigurupati Uma Devi	Preferential Offer	Buy	24,880,342
2026-10-23	Harsha Chigurupati	Preferential Offer	Buy	34,188
2026-10-23	Harsha Chigurupati	Preferential Offer	Buy	34,188
2026-10-23	Pragnya Chigurupati	Preferential Offer	Buy	34,188
2026-10-23	Pragnya Chigurupati	Preferential Offer	Buy	34,188
2026-10-23	Priyanka Chigurupati	Preferential Offer	Buy	34,188
2026-10-23	Priyanka Chigurupati	Preferential Offer	Buy	34,188

Sector Overview

HealthcarePharmaceuticals & Drugs

Granules India Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

13 members across the board and senior leadership

Chaitanya Tummala

Company Secretary & Compliance Officer

—

Krishna Prasad Chigurupati

Chairman & Managing Director

₹28.36 Cr

Mar '26

Priyanka Chigurupati

Executive Director

₹2.84 Cr

Mar '26

Harsha Chigurupati

Executive Director

₹2.84 Cr

Mar '26

Uma Devi Chigurupati

Executive Director

₹2.84 Cr

Mar '26

KB Sankar Rao

Non Independent & Non Executive Director

₹39.11 L

Mar '26

Kolli Basava Sankar Rao

Non Independent & Non Executive Director

₹29.10 L

Mar '25

Arun Sawhney